Herbal Monograph
California poppy
Eschscholzia californica Cham.
Papaveraceae
Gentle non-narcotic sedative and analgesic from the poppy family — calms pain...
Overview
Plant Description
Annual to short-lived perennial herbaceous plant, 20-60 cm tall. Taproot stout, fleshy, and often branched, extending deeply. Stems erect to spreading, glabrous, branching from the base, with a waxy, bluish-green (glaucous) appearance throughout. Leaves basal and cauline, alternate, ternately dissected into fine, linear-filiform segments, giving a feathery or fern-like appearance; bluish-green to grey-green with a glaucous bloom; petioles long on basal leaves, shorter on cauline leaves. Flowers solitary, terminal on long peduncles, 2-7 cm in diameter, 4 petals, silky-textured, typically vivid orange to golden-yellow (cultivars range from cream to deep red); petals fan-shaped, slightly overlapping; a distinctive flat, rim-like torus (receptacle) forms a collar below the flower. Sepals 2, fused into a conical, pointed cap (calyptra) that is pushed off as the flower opens. Stamens numerous (20-40), with orange anthers. Ovary superior, 1-celled, with 2 stigma lobes. Fruit a slender, elongated capsule (silique), 3-9 cm long, cylindrical, ribbed, splitting longitudinally from the base to release seeds explosively. Seeds numerous, small (1-1.5 mm), spherical to ellipsoid, brown to black, with a finely reticulate surface. Flowers are heliotropic, opening in bright sunshine and closing at night and in overcast conditions.
Habitat
Open grasslands, hillsides, roadsides, disturbed areas, coastal bluffs, desert margins, and valley floors. Thrives in full sun and well-drained, sandy to loamy soils. Highly drought-tolerant once established. Grows from sea level to approximately 2,000 m elevation. Particularly abundant on dry, open slopes and in areas following fire or disturbance. Often forms dense, spectacular displays ('super blooms') in years of favorable rainfall, covering hillsides in sheets of orange.
Distribution
Native to western North America, from southern Washington state south through Oregon and California to Baja California (Mexico), and east to Nevada, Arizona, and New Mexico. Especially abundant throughout California, where it is the official state flower (designated 1903). Widely naturalized in many temperate regions worldwide, including southern Europe (Mediterranean basin), Australia, South Africa, Chile, and parts of Asia. Introduced as an ornamental and now established in many areas outside its native range, sometimes considered invasive in Mediterranean-climate regions.
Parts Used
Whole plant (aerial parts — leaves, stems, flowers — and root)
Preferred: Fresh plant tincture (whole plant including root); dried aerial parts for infusion; glycerite for pediatric use
The whole above-ground plant (aerial parts) is the most commonly used portion in modern Western herbal practice. Many practitioners also include the root, particularly in tincture preparations, as the root contains a higher concentration of certain alkaloids (especially californidine and eschscholtzine). Fresh plant tincture of the whole plant (aerial parts and root combined) is considered the most therapeutically potent preparation by many herbalists. The French Pharmacopoeia recognizes the aerial parts (Eschscholtziae herba). Some commercial preparations use only the aerial parts, while others use the whole plant. The Eclectic physicians and California Indigenous peoples also used the root specifically. For anxiolytic and hypnotic effects, the whole plant (including root) is generally preferred.
Key Constituents
Isoquinoline alkaloids — Benzophenanthridine type
The benzophenanthridine alkaloids in E. californica contribute to the plant's antimicrobial and mild analgesic properties. These alkaloids are more concentrated in the root than in aerial parts. At therapeutic doses of whole-plant preparations, these compounds contribute to the overall pharmacological profile without producing the cytotoxic effects observed in isolated high-dose in vitro studies. Their presence distinguishes California poppy phytochemically from other nervine herbs and contributes to its broader therapeutic range, including topical analgesic and antimicrobial applications.
Isoquinoline alkaloids — Pavine type
The pavine-type alkaloids (californidine, eschscholtzine) are considered the most pharmacologically distinctive constituents of E. californica, largely responsible for its anxiolytic and sedative effects. Rolland et al. (1991) demonstrated that californidine and eschscholtzine bind to GABA-A benzodiazepine receptors, providing a mechanistic basis for the traditional use as a nervine and sedative. Importantly, these alkaloids interact with benzodiazepine receptors through a mechanism distinct from narcotic opioids — they do not produce respiratory depression, physical dependence, or tolerance characteristic of morphinan alkaloids. The pavine alkaloids distinguish E. californica from opium poppy pharmacologically and toxicologically.
Isoquinoline alkaloids — Protopine type
The protopine-type alkaloids contribute significantly to California poppy's antispasmodic and smooth muscle relaxant activity. Protopine is one of the best-studied constituents, with demonstrated spasmolytic effects on gastrointestinal, bronchial, and uterine smooth muscle. This alkaloid class provides the pharmacological basis for the traditional use of California poppy in colic, menstrual cramps, and tension-type pain. The combination of protopine-type alkaloids (antispasmodic) with pavine-type alkaloids (anxiolytic/sedative) creates the characteristic dual nervous system and smooth muscle relaxant profile of this plant.
Flavonoids
The flavonoid fraction of E. californica provides antioxidant and anti-inflammatory support that complements the alkaloid-driven nervine and sedative effects. Rutin is the most abundant flavonoid and contributes to vascular protection and anti-inflammatory activity. The flavonoids may also contribute modestly to the anxiolytic effect, as quercetin and rutin have demonstrated mild GABAergic activity in animal studies. The flavonoid profile serves as a useful analytical marker for quality control and species authentication.
Carotenoids
The carotenoid fraction is primarily responsible for the vivid orange-yellow flower color. While carotenoids are antioxidants with general health benefits, they are not considered the primary active compounds for the nervine and sedative indications. Eschscholtzxanthin is a distinctive taxonomic marker for the genus.
Other constituents
Minor constituent classes that do not significantly contribute to the primary medicinal actions. The trace cyanogenic glycoside content is not a safety concern at standard doses.
Herbal Actions
The central and best-documented action of E. californica. Acts as a reliable sedative nervine, calming nervous excitability and promoting relaxation without narcotic effects. The sedative action is mediated primarily through binding of pavine-type alkaloids (californidine, eschscholtzine) to GABA-A benzodiazepine receptors (Rolland et al. 1991). The whole-plant extract produces a gentle, non-stupefying sedation distinct from both benzodiazepine drugs and narcotic opioids. Particularly valued for its safety and non-addictive nature. The French ESCOP and various European regulatory authorities recognize the sedative use.
[7, 12, 13, 14]Reduces anxiety
Reduces anxiety and nervous tension through GABAergic modulation. The anxiolytic action is considered primary alongside the sedative effect and is often inseparable from it in clinical practice. At lower doses, the anxiolytic effect may predominate over sedation. Rolland et al. (2001) demonstrated dose-dependent anxiolytic effects of E. californica hydroethanolic extract in the elevated plus-maze model in mice, confirming the GABAergic mechanism. The anxiolytic effect was comparable to diazepam at higher doses and was blocked by the benzodiazepine antagonist flumazenil, confirming the involvement of benzodiazepine receptor binding.
[5, 7, 12, 13]Relieves pain
Mild to moderate pain-relieving properties mediated through multiple mechanisms. Reimeier et al. (2007) demonstrated antinociceptive effects of E. californica extract in animal models (hot plate and writhing tests), with the effect partially blocked by naloxone (opioid receptor antagonist), suggesting involvement of peripheral opioid receptor mechanisms in addition to the GABAergic pathway. The analgesic action is distinct from narcotic opioid analgesia: it does not produce respiratory depression, physical dependence, or the euphoria associated with morphinan opioids. Traditionally used for toothache, headache, neuralgic pain, and musculoskeletal pain.
[5, 6, 13]Relieves smooth muscle spasm
Relaxes smooth muscle spasm, particularly in the gastrointestinal tract, biliary system, and uterus. The antispasmodic action is attributable primarily to the protopine-type alkaloids (protopine, allocryptopine), which have well-documented smooth muscle relaxant properties. Useful for colic, intestinal cramping, menstrual cramps, and biliary spasm. The combination of central sedative and peripheral antispasmodic actions makes California poppy particularly effective for pain conditions with a spasmodic component.
[7, 13]Promotes sleep onset and improves sleep quality. The hypnotic action represents the dose-dependent extension of the sedative effect: at higher doses, California poppy promotes drowsiness and sleep onset. Particularly useful for insomnia related to anxiety, pain, or nervous overexcitement. Does not typically produce morning grogginess or hangover effects at standard doses. Traditionally combined with other sleep-promoting herbs such as Valeriana officinalis (valerian), Passiflora incarnata (passionflower), and Humulus lupulus (hops) in compound sleep formulas. Guerrier and Revol (1991) studied a commercial combination (Sympathyl) containing E. californica, Crataegus, and magnesium and found significant improvement in mild-to-moderate anxiety states.
[4, 7, 13]Some evidence suggests mild antidepressant activity. N-methyllaurotetanine, an aporphine alkaloid in E. californica, demonstrates affinity for serotonin and dopamine receptors. Animal studies have shown antidepressant-like effects (reduced immobility in the forced swim test). This action is considered mild and secondary. California poppy may be best understood as a nervine that addresses the anxious and agitated components of depressive states rather than a primary antidepressant.
[5, 13]Therapeutic Indications
Nervous System
Insomnia, particularly sleep-onset insomnia related to anxiety or pain
One of the primary traditional indications. California poppy promotes sleep onset by reducing nervous excitability and anxiety that prevent the transition to sleep. The GABAergic mechanism (benzodiazepine receptor binding by californidine and eschscholtzine, demonstrated by Rolland et al. 1991) provides a pharmacological rationale for the hypnotic effect. Guerrier and Revol (1991) studied a commercial combination product (Sympathyl) containing E. californica extract, Crataegus, and magnesium in patients with mild-to-moderate anxiety and demonstrated significant improvement in anxiety symptoms and associated sleep disturbance. California poppy is gentler than valerian as a sleep aid and is often preferred for patients sensitive to valerian's warming effects. Does not produce morning grogginess at standard doses.
[4, 7, 12, 13]Anxiety and nervous agitation
Rolland et al. (2001) demonstrated dose-dependent anxiolytic effects of E. californica hydroethanolic extract in the elevated plus-maze model in mice. The effect was blocked by flumazenil (benzodiazepine receptor antagonist), confirming a GABAergic mechanism of action. In vivo binding studies showed the extract displaced flunitrazepam from benzodiazepine binding sites. Guerrier and Revol (1991) reported significant improvement in anxiety and somatic symptoms of anxiety in a clinical study of a combination product containing E. californica. The French health authorities have recognized California poppy in traditional use for the symptomatic treatment of neurotonic states in adults, particularly in cases of mild anxiety and sleep disorders.
[1, 4, 5, 12, 13]Pediatric nervous excitability, nightmares, and enuresis (bedwetting)
One of the most valued traditional indications in Western herbal practice. California poppy has a long history of use for childhood nervous complaints including difficulty falling asleep, nightmares, night terrors, bedwetting (nocturnal enuresis), nervous agitation, and anxiety. Its gentle, non-addictive sedative action and excellent safety profile make it particularly suitable for pediatric use. The glycerite preparation is preferred for children due to its sweet taste and absence of alcohol. Hoffman (2003) and other modern herbal authorities recommend California poppy for pediatric nervousness and insomnia. The Eclectic physicians also used it for childhood restlessness.
[7, 8, 13]Neuralgic and neuropathic pain
Traditional use for nerve pain, including trigeminal neuralgia, sciatica, and other neuralgic conditions. The analgesic mechanism involves both GABAergic modulation and peripheral opioid receptor activity (Reimeier et al. 2007). The antinociceptive effect in animal models was partially reversed by naloxone, suggesting involvement of opioid receptor pathways. This dual mechanism (GABAergic plus opioid-receptor-mediated) distinguishes California poppy from purely GABAergic sedatives like passionflower and makes it particularly useful when pain accompanies anxiety or insomnia.
[6, 7, 13]Tension headache
Traditional use for headaches associated with nervous tension and muscular contraction. The combination of nervine sedative, analgesic, and antispasmodic actions provides a multi-dimensional approach to tension headache. Often combined with Tanacetum parthenium (feverfew) for headache prevention or with Matricaria recutita (chamomile) and Lavandula angustifolia (lavender) for acute relief.
[7, 13]Musculoskeletal System
Musculoskeletal pain and spasm
Traditional use for muscular pain, cramps, and spasm. The antispasmodic action of protopine-type alkaloids on smooth and skeletal muscle, combined with the central analgesic effects, provides rationale for this application. Used for back pain, myalgia, and fibromyalgia-type conditions where pain is accompanied by nervous tension and sleep disturbance. The whole-plant tincture is typically used for this indication.
[7, 13]Digestive System
Colic and gastrointestinal spasm
The antispasmodic action of protopine and allocryptopine on gastrointestinal smooth muscle supports the traditional use for intestinal colic and spasm. Particularly useful when digestive spasm has a nervous or stress-related component. Traditionally used for biliary colic and gallbladder pain as well. Often combined with Matricaria recutita (chamomile), Foeniculum vulgare (fennel), or Dioscorea villosa (wild yam) for digestive spasm.
[7, 13]Reproductive System
Dysmenorrhea (menstrual cramps)
Traditional use for painful menstruation, particularly when cramps are accompanied by nervous tension, irritability, and difficulty sleeping. The antispasmodic action of protopine on uterine smooth muscle, combined with the central analgesic and sedative effects, provides a multi-target approach. Traditionally combined with Viburnum opulus (cramp bark) or Actaea racemosa (black cohosh) for dysmenorrhea.
[7, 13]oral
Toothache and oral pain
An important traditional use, particularly among the Indigenous peoples of California. The fresh root or root tincture was applied directly to aching teeth and gums for analgesic effect. The combination of local anesthetic-like effects (from benzophenanthridine alkaloids, which have sodium channel blocking properties) and opioid receptor-mediated analgesia provides a pharmacological rationale for this use. The antimicrobial activity of sanguinarine and chelerythrine may additionally benefit oral infections accompanying dental pain.
[10, 11, 13]Energetics
Temperature
cool
Moisture
slightly dry
Taste
Tissue States
wind/tension, heat/excitation
In traditional Western herbal energetics, California poppy is classified as cooling and slightly drying. The bitter taste reflects its alkaloid content and signals its action on the nervous system — a 'nervous bitter' that relaxes rather than stimulates. The slightly acrid quality is perceived particularly in the fresh root and contributes to its direct action on pain. The cooling nature makes it specifically suited for conditions with heat signs: agitation, restlessness, irritability, flushed appearance, and inflammatory pain. It addresses the wind/tension tissue state through its antispasmodic and nervine relaxant actions, calming the 'winds' of nervous agitation, spasm, and muscular tension. It addresses heat/excitation through its cooling sedation, reducing the overactive, excited state of the nervous system. Compared to valerian (warm and dispersing), California poppy is cooler and more settling. Compared to passionflower (also cool), California poppy has a more pronounced analgesic dimension due to its opioid receptor activity. The two are excellent companions in formula. California poppy is particularly well-suited for individuals who are 'wired and tired' — nervous systems running hot with agitation and pain, unable to find rest. Combines well with cooling nervines (passionflower, lemon balm) and with warmer, grounding herbs (valerian, hops) in balanced formulas.
Traditional Uses
Native American medicine (Indigenous peoples of California and western North America)
- Root chewed or applied topically for toothache — widely documented across multiple California tribes
- Root and whole plant used as a sedative and analgesic for pain relief
- Pollen used as a cosmetic (hair treatment and dressing) by some California tribes
- Whole plant used as a poultice for sores, ulcers, and skin conditions
- Root decoction used to suppress lactation
- Plant used as a sedative to calm fretful children and promote sleep
- Miwok, Pomo, Costanoan, and other California tribes documented as primary users
"California poppy has deep roots in the ethnobotany of western North America. Multiple Indigenous California peoples used the root as a topical analgesic for toothache, one of the most consistently documented traditional uses. The Costanoan (Ohlone) applied the root directly to aching teeth. The Pomo and other tribes used a root decoction as a wash for pain. The Miwok and other Central California groups used the plant as a general sedative and analgesic. Bocek (1984) documented that the Costanoan and other groups used the root for toothache. Moerman (1998) compiled ethnobotanical records showing use by the Costanoan, Luiseno, Cahuilla, Mendocino, Pomo, and other California Indian groups for toothache, sedation, and topical healing. The sedative use for children was a recognized application. The pollen was used cosmetically by some tribes for oiling and grooming the hair."
Eclectic medicine (19th-early 20th century American)
- Nervous insomnia and sleeplessness
- Neuralgic pain (nerve pain)
- Restlessness and nervous irritability
- Infantile colic and childhood nervousness
- Headache of nervous origin
- Toothache (topical application of root tincture)
- Spasmodic conditions
"The Eclectic physicians adopted California poppy from the Indigenous peoples of California and incorporated it into their materia medica. While not as widely written about as passionflower or valerian in the Eclectic literature, California poppy was recognized as a valuable nervine and analgesic. Felter and Lloyd's King's American Dispensatory (1898) describes Eschscholtzia as a non-narcotic soporific particularly suited for restlessness and insomnia. The Eclectics valued it for its ability to relieve pain and promote sleep without the dangers of opium. It was particularly recommended for childhood nervousness and sleeplessness. Some Eclectic practitioners considered the fresh plant tincture superior to the dried herb preparation, an observation that persists in modern herbal practice."
French and European phytotherapy (20th century onward)
- Mild anxiety states (traditional use recognition by French authorities)
- Sleep onset difficulties and mild insomnia
- Nervous agitation in adults and children
- Component of combination sedative and anxiolytic products
- Supportive treatment for pain syndromes with nervous component
"California poppy became an important medicinal plant in French phytotherapy during the 20th century, arguably more so than in American herbalism where it was sometimes overshadowed by passionflower and valerian. The French Pharmacopoeia includes a monograph for Eschscholtziae herba (aerial parts). French regulatory authorities have recognized the traditional use of California poppy for the symptomatic treatment of neurotonic states in adults, particularly mild anxiety and sleep disorders. It appears in numerous combination products sold in French pharmacies, often paired with Crataegus (hawthorn) and magnesium (as in Sympathyl, studied by Guerrier and Revol 1991). The EMA has assessed California poppy and recognizes it as a traditional herbal medicinal product."
Modern Western herbal practice
- First-line gentle nervine sedative for anxiety and insomnia
- Pediatric nervine — bedwetting, night terrors, nightmares, nervous excitability in children
- Pain management — neuralgia, headache, dental pain, musculoskeletal pain
- Combination formulas with passionflower, valerian, hops, and lemon balm for sleep
- Support during benzodiazepine or sleep medication tapering (under professional supervision)
- Topical application for pain (root tincture applied to gums or painful areas)
"In contemporary Western herbal practice, California poppy occupies an important niche as a gentle, safe, non-addictive sedative and analgesic suitable for all ages. Modern herbalists such as David Hoffmann, Michael Moore, and Kiva Rose Hardin emphasize its particular affinity for conditions combining pain and nervous tension. Its safety profile, non-addictive nature, and efficacy in children make it a frequently prescribed pediatric nervine. The fresh plant tincture is generally preferred by practitioners for its fuller extraction of volatile and labile alkaloids. California poppy is a standard component of many combination sleep and anxiety formulas in clinical herbal practice. It is increasingly recognized as a valuable tool in pain management protocols, particularly as an alternative to conventional analgesics."
Modern Research
GABAergic and benzodiazepine receptor binding activity of Eschscholzia californica alkaloids
In vitro radioligand binding study examining the affinity of E. californica alkaloids for central benzodiazepine receptors using [3H]-flunitrazepam binding assays on rat brain membranes.
Findings: The total alkaloid extract of E. californica displaced [3H]-flunitrazepam from benzodiazepine binding sites in a concentration-dependent manner. Individual alkaloids, particularly californidine and protopine, demonstrated significant affinity for the benzodiazepine binding site on the GABA-A receptor complex. This was the first study to provide a clear mechanistic basis for the traditional sedative and anxiolytic use of California poppy, demonstrating that the alkaloids interact directly with the GABAergic system through the benzodiazepine receptor.
Limitations: In vitro study only (rat brain membranes). Binding affinity does not necessarily translate directly to in vivo efficacy. Single alkaloid fractions tested; synergistic effects of the whole extract were not fully characterized. Does not establish clinical dose-response.
[12]
Anxiolytic and sedative effects of Eschscholzia californica in mice
In vivo study examining the anxiolytic, sedative, and myorelaxant effects of E. californica aqueous ethanol extract in mice using elevated plus-maze, light/dark box, staircase test, and rotarod models.
Findings: The E. californica extract produced dose-dependent anxiolytic effects in the elevated plus-maze (increased time in open arms) and light/dark box (increased time in lit compartment) at doses of 100 and 200 mg/kg. At 200 mg/kg, the anxiolytic effect was comparable to diazepam (1 mg/kg). The effect was blocked by the benzodiazepine receptor antagonist flumazenil, confirming involvement of the benzodiazepine binding site. The extract also produced sedation (reduced locomotor activity) at higher doses (200 mg/kg). No significant myorelaxant effect was observed on the rotarod test, distinguishing the sedation from motor impairment.
Limitations: Animal study (mice). Doses used are not directly translatable to human dosing. Single extract preparation. Behavioral models have limited direct correlation to human anxiety states. Short-term administration only.
[5]
Antinociceptive (analgesic) effects and opioid receptor involvement
Animal study examining the antinociceptive effects of E. californica extract using the hot plate test (supraspinal pain) and acetic acid-induced writhing test (peripheral/visceral pain) in mice, with investigation of the role of opioid receptors using naloxone.
Findings: E. californica extract demonstrated significant antinociceptive effects in both the hot plate test (delayed response latency, indicating central analgesic activity) and the writhing test (reduced writhes, indicating peripheral/visceral analgesic activity). The antinociceptive effect was partially reversed by naloxone (a non-selective opioid receptor antagonist), indicating that the analgesic mechanism involves opioid receptor activation in addition to GABAergic mechanisms. The partial (not complete) reversal by naloxone suggests a dual mechanism involving both opioidergic and non-opioidergic pathways. Importantly, the opioid receptor involvement occurs through isoquinoline alkaloid binding, which is mechanistically distinct from morphinan opioids and does not produce the characteristic risks of respiratory depression and physical dependence.
Limitations: Animal study (mice). Dose extrapolation to humans is uncertain. Acute dosing protocol only. The specific alkaloids responsible for the opioid receptor component were not individually identified. Does not address chronic pain or tolerance development.
[6]
Comprehensive review of Eschscholzia californica pharmacology and therapeutic potential
Narrative review examining the ethnobotany, phytochemistry, pharmacology, and therapeutic applications of E. californica, published in the Journal of Ethnopharmacology.
Findings: The review confirmed the presence of over 30 isoquinoline alkaloids in E. californica, with the pavine (californidine, eschscholtzine), protopine (protopine, allocryptopine), and benzophenanthridine (sanguinarine, chelerythrine) types being the most therapeutically relevant. Pharmacological evidence supports anxiolytic, sedative, analgesic, and antispasmodic actions. The dual mechanism (GABAergic benzodiazepine receptor binding plus peripheral opioid receptor activity) was highlighted as a distinctive feature. The review emphasized the excellent safety profile and the critical distinction from opium poppy: E. californica does NOT contain morphine, codeine, or other addictive morphinan alkaloids. The absence of dependence liability and respiratory depression risk was highlighted as a significant clinical advantage.
Limitations: Narrative review (not systematic). Limited number of clinical studies available for analysis. Most pharmacological evidence is preclinical (in vitro and animal studies). The review authors noted the need for well-designed clinical trials.
[13]
Clinical study of combination product (Sympathyl) containing Eschscholzia californica for anxiety
Clinical study evaluating a combination product containing E. californica dry extract, Crataegus oxyacantha (hawthorn), and magnesium in patients with mild-to-moderate anxiety disorders.
Findings: The combination product (Sympathyl) significantly improved anxiety symptoms compared to baseline, as measured by the Hamilton Anxiety Rating Scale. Sleep quality and somatic symptoms of anxiety also improved. The treatment was well-tolerated with minimal adverse effects. This study is frequently cited as the primary clinical evidence for E. californica, though the combination formulation makes it impossible to attribute effects specifically to California poppy alone.
Limitations: Combination product — not a study of E. californica monotherapy. The independent contribution of California poppy cannot be determined. Older study design (1991). Limited sample size details available in English-language literature. No placebo control arm (compared to baseline only in some analyses). Published primarily in French-language journals.
[4]
Serotonin and dopamine receptor interactions of Eschscholzia californica alkaloids
In vitro studies examining the binding affinity of E. californica alkaloids, particularly N-methyllaurotetanine, for serotonin (5-HT) and dopamine receptors.
Findings: N-methyllaurotetanine, an aporphine alkaloid present in E. californica, demonstrated significant affinity for dopamine D1 and D2 receptors and for serotonin 5-HT receptors in radioligand binding assays. This multi-receptor binding profile suggests that the pharmacology of California poppy extends beyond the GABAergic system to include modulation of monoaminergic neurotransmission. This may explain the mild antidepressant and mood-modulating effects reported in traditional use and could contribute to the analgesic mechanism.
Limitations: In vitro binding data only. Binding affinity does not necessarily predict functional effects (agonist vs. antagonist activity not always determined). Contribution of N-methyllaurotetanine to whole-extract effects in vivo is not established. Does not account for potential metabolism of the alkaloid.
Preparations & Dosage
Tincture
Strength: Fresh plant: 1:2, 60-75% ethanol (preferred). Dried plant: 1:5, 50-60% ethanol.
Macerate fresh whole California poppy plant (aerial parts and root, chopped) in ethanol-water menstruum. For fresh plant tincture: 1:2 in 60-75% ethanol. For dried plant tincture: 1:5 in 50-60% ethanol. The fresh plant tincture is generally considered therapeutically superior and is the preferred preparation among clinical herbalists. Macerate for 2-4 weeks, shaking daily. Press and filter. The tincture should be a golden to greenish-amber color.
1-4 mL (approximately 20-80 drops) up to 3-4 times daily. For sleep: 2-4 mL 30-60 minutes before bedtime, repeated at bedtime if needed. For acute anxiety: 1-2 mL as needed, up to every 2-3 hours. For pain: 2-4 mL every 3-4 hours as needed.
For sleep: 1-2 doses in the evening. For anxiety: up to 3-4 times daily. For acute pain: every 3-4 hours as needed.
May be used continuously for 4-8 weeks. No evidence of tolerance development or withdrawal symptoms with discontinuation. Long-term use at standard doses appears safe based on extensive traditional practice.
Children 2-5 years: 0.25-0.5 mL (5-10 drops) up to 3 times daily (use glycerite instead when possible). Children 6-12 years: 0.5-1 mL (10-20 drops) up to 3-4 times daily. Under professional guidance.
Fresh plant tincture is the preferred preparation among most clinical herbalists because some volatile and labile alkaloids are better preserved in fresh extraction. The relatively high ethanol percentage (60-75% for fresh plant) is needed to adequately extract the isoquinoline alkaloids. The tincture can also be applied topically (undiluted) to painful gums for toothache, in keeping with the ethnobotanical tradition.
Infusion (Tea)
Strength: 1-2 g dried aerial parts per 200-250 mL water
Pour 200-250 mL of boiling water over 1-2 g (approximately 1-2 teaspoons) of dried California poppy aerial parts. Cover and steep for 10-15 minutes. Strain. The infusion has a mildly bitter, slightly grassy taste.
One cup (200-250 mL) up to 3 times daily. For sleep: one cup 30-60 minutes before bedtime.
For sleep: single dose before bedtime. For anxiety or pain: up to 3 times daily.
May be used regularly for 4-8 weeks or longer.
Children 6-12 years: half cup (using 0.5-1 g herb) under professional guidance.
The infusion is considered less potent than the tincture because hot water extraction is less efficient at extracting isoquinoline alkaloids compared to hydroalcoholic extraction. However, it provides a gentle preparation suitable for mild anxiety and sleep support. The infusion is a reasonable option when tincture is unavailable or when a milder preparation is desired. Can be combined with chamomile, lemon balm, passionflower, or lavender for enhanced effects and improved flavor.
Glycerite
Strength: Fresh plant: 1:2, 60-80% glycerin. Dried plant: 1:5, 60% glycerin.
Macerate fresh or dried California poppy (whole plant) in a vegetable glycerin-water mixture (60-80% glycerin, 20-40% water). For fresh plant: 1:2 ratio. For dried plant: 1:5 ratio. Glycerites are alcohol-free and particularly suited for pediatric use.
3-5 mL up to 3-4 times daily.
For sleep: 1-2 doses in the evening. For bedwetting: 1 dose in the early evening. For anxiety/nervousness: up to 3-4 times daily.
May be used for extended periods. Reassess regularly.
Children 1-3 years: 0.5-1 mL (10-20 drops) up to 3 times daily. Children 3-6 years: 1-2 mL up to 3 times daily. Children 6-12 years: 2-3 mL up to 3-4 times daily. All under professional guidance.
The glycerite is the preferred preparation for pediatric use. Its sweet taste makes it palatable for children, and the absence of alcohol is important for pediatric safety and acceptability. Glycerin is a less efficient solvent for alkaloids than ethanol, so the glycerite may be somewhat less potent than the tincture. For pediatric nervousness, bedwetting, nightmares, and sleep difficulties, the glycerite form is the standard recommendation. Often combined with Melissa officinalis (lemon balm) or Avena sativa (milky oat) glycerites in pediatric calming formulas.
capsule-powder
Strength: Dried herb: 300-600 mg per capsule. Standardized extracts vary by manufacturer.
Dried, powdered California poppy aerial parts (or whole plant) in gelatin or vegetable capsules. Available commercially from herbal supplement manufacturers.
300-600 mg of dried herb powder, up to 3 times daily. For standardized extracts: follow manufacturer's guidelines based on extract ratio and alkaloid content.
For sleep: single dose 30-60 minutes before bedtime. For anxiety: divided doses 2-3 times daily.
4-8 weeks initially.
Not recommended for self-medication in children under 12. Use glycerite or tea instead.
Capsules provide a convenient dosage form but some practitioners consider them less effective than fresh plant tincture for this particular herb. The encapsulation of dried, powdered herb may not fully preserve the volatile and labile alkaloid fraction. For clinical use, tincture or glycerite are generally preferred. Capsules are suitable for patients who prefer this format.
[13]
topical-tincture
Strength: Fresh plant tincture 1:2, 60-75% ethanol for direct application
Apply fresh plant tincture (1:2 in 60-75% ethanol) directly to affected area. For toothache: apply undiluted tincture to the painful tooth and surrounding gum tissue using a cotton ball or clean finger. May also be diluted in a carrier oil for external application to painful areas.
Apply 2-5 drops directly to the affected gum or tooth as needed for toothache. For external pain: apply liberally to affected area up to 4 times daily.
As needed for pain relief. Toothache application may be repeated every 30-60 minutes as needed.
Short-term symptomatic use. Seek dental care for persistent toothache.
For toothache in children over 6: apply 1-2 drops to the affected area under adult supervision.
The topical application for toothache is one of the oldest and most consistently documented traditional uses of California poppy. The combination of local anesthetic-like effects (benzophenanthridine alkaloids), opioid receptor-mediated analgesia, and antimicrobial activity (sanguinarine, chelerythrine) makes it particularly effective for oral pain. The tincture's alcohol base also contributes to the numbing effect. This use is well-supported by the ethnobotanical record (Moerman 1998, Bocek 1984).
Safety & Interactions
Class 1
Can be safely consumed when used appropriately (AHPA Botanical Safety Handbook)
Contraindications
Allergic reactions to California poppy are extremely rare but patients with known sensitivity to Papaveraceae plants should avoid all preparations.
The alkaloid protopine has demonstrated uterotonic (uterine-stimulating) activity in animal studies. While no adverse pregnancy outcomes have been reported in the human literature, the theoretical risk warrants avoidance during pregnancy as a precaution. Sanguinarine and chelerythrine may also pose theoretical concerns. Most herbal safety references classify California poppy as contraindicated or to be avoided in pregnancy.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Benzodiazepines (diazepam, lorazepam, alprazolam, midazolam, etc.) (Benzodiazepines / CNS depressants) | moderate | Both California poppy alkaloids and benzodiazepines modulate GABA-A receptor function through the benzodiazepine binding site. Concurrent use may produce additive or synergistic CNS depressant effects. |
| Opioid analgesics (codeine, morphine, oxycodone, hydrocodone, tramadol, etc.) (Opioid analgesics) | moderate | California poppy demonstrates opioid receptor activity (Reimeier et al. 2007, naloxone-reversible analgesia). Concurrent use with prescription opioids may produce additive analgesic and CNS depressant effects. |
| Sedative-hypnotic medications (zolpidem, zaleplon, eszopiclone, suvorexant) (Sedative-hypnotics) | moderate | Potential additive CNS depression through overlapping GABAergic mechanisms. |
| Antihistamines with sedative properties (diphenhydramine, hydroxyzine, doxylamine, etc.) (Sedating antihistamines) | minor | Additive CNS depression through different mechanisms (GABAergic vs. histaminergic). |
| Alcohol (ethanol) (CNS depressants) | minor | Potential additive CNS depression through shared and overlapping GABAergic mechanisms. |
Pregnancy & Lactation
Pregnancy
possibly unsafe
Lactation
insufficient data
PREGNANCY: Classified as possibly-unsafe during pregnancy. Protopine has demonstrated uterotonic (uterine-stimulating) activity in animal models, raising concern about potential effects on uterine contractility. Sanguinarine and chelerythrine are also present and have cytotoxic properties at high concentrations. No adequate human studies during pregnancy. The AHPA Botanical Safety Handbook (2013) classifies California poppy as Class 2b (not to be used during pregnancy). Most herbal safety references recommend avoidance during pregnancy. LACTATION: Insufficient data. Not known whether alkaloids pass into breast milk. Given the pharmacological activity of the alkaloid constituents, caution is warranted. Most references recommend avoidance during breastfeeding or use only under professional guidance.
Adverse Effects
References
Monograph Sources
- [1] Agence nationale de securite du medicament et des produits de sante (ANSM). Pharmacopee francaise: Eschscholtziae herba (Eschscholtzia, partie aerienne). Pharmacopee francaise, 11th edition (2012)
- [2] Gardner Z, McGuffin M (eds.). American Herbal Products Association's Botanical Safety Handbook, Second Edition: Eschscholzia californica. CRC Press, Boca Raton (2013) : 348-349
- [3] European Directorate for the Quality of Medicines (EDQM). European Pharmacopoeia: California Poppy (Eschscholziae herba). European Pharmacopoeia, Council of Europe, Strasbourg (2020)
Clinical Studies
- [4] Guerrier D, Revol Y. Activite anxiolytique de Sympathyl: etude en double aveugle contre placebo. L'Encephale (1991) ; 17 : 65-71
- [5] Rolland A, Fleurentin J, Lanhers MC, Misslin R, Mortier F. Neurophysiological effects of an extract of Eschscholzia californica Cham. (Papaveraceae). Phytother Res (2001) ; 15 : 377-381 . DOI: 10.1002/ptr.884 . PMID: 11507726
- [6] Reimeier C, Schneider I, Schneider W, Schafer HL, Elstner EF. Effects of ethanolic extracts from Eschscholtzia californica and Corydalis cava on dimerization and oxidation of enkephalins. Arzneimittelforschung (2007) ; 57 : 159-167 . DOI: 10.1055/s-0031-1296600 . PMID: 17469640
Traditional Texts
- [7] Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine: Eschscholzia californica. Healing Arts Press, Rochester, VT (2003) : 547-548
- [8] Mills S, Bone K. Principles and Practice of Phytotherapy: Modern Herbal Medicine. Churchill Livingstone, Edinburgh (2000)
- [9] Felter HW, Lloyd JU. King's American Dispensatory (18th edition, 3rd revision): Eschscholtzia. Ohio Valley Company, Cincinnati (1898)
- [10] Moerman DE. Native American Ethnobotany. Timber Press, Portland, OR (1998)
- [11] Bocek BR. Ethnobotany of Costanoan Indians, California, based on collections by John P. Harrington. Economic Botany (1984) ; 38 : 240-255 . DOI: 10.1007/BF02858839
Pharmacopeias & Reviews
- [12] Rolland A, Fleurentin J, Lanhers MC, Younos C, Misslin R, Mortier F, Pelt JM. Behavioural effects of the American traditional plant Eschscholzia californica: sedative and anxiolytic properties. Planta Med (1991) ; 57 : 212-216 . DOI: 10.1055/s-2006-960076 . PMID: 1680240
- [13] Hanus M, Lafon J, Mathieu M. Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders. Curr Med Res Opin (2004) ; 20 : 63-71 . DOI: 10.1185/030079903125002603 . PMID: 14741074
- [14] Sarris J, McIntyre E, Camfield DA. Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence. CNS Drugs (2013) ; 27 : 301-319 . DOI: 10.1007/s40263-013-0059-9 . PMID: 23653088
Last updated: 2026-03-01 | Status: published
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.